Synergistic effect of components of Xiongshao capsule on reducing cholesterol content and inflammation in foam cells derived from RAW264.7 cells
Author:
Affiliation:

1.Graduate School, China Academy of Chinese Medical Sciences, Beijing 100700;2.Institute of Geriatrics, China Academy of Chinese Medical Sciences, Beijing 100091;3.Institute of Cardiovascular Disease, China Academy of Chinese Medical Sciences, Beijing 100091)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference [29]
  • | | | |
  • Comments
    Abstract:

    Aim To observe the effects of components of Xiongshao capsule on cholesterol and inflammatory factors on foam cells in vitro. Methods Oxidized low-density lipoprotein (ox-LDL) was used to induce the foaming of RAW264.7 cells. The proliferation activity of foam cells was detected by CCK-8 reagent. The total cholesterol (TC) and free cholesterol (FC) in foam cells were detected by cholesterol test kit, and the lipid distribution in cells was observed by oil red staining. The concentration of inflammatory factors, tumor necrosis factor alpha (TNF-α) and interleukin 1beta (IL-1β) was detected by ELISA kit. Results The results of CCK-8 showed that ligustrazine and paeoniflorin had no obvious effect on the proliferation of foam cells under 80 mg/L concentration. 40 mg/L ligustrazine plus 80 mg/L paeoniflorin could significantly reduce TC and FC contents in foam cells, reduce lipid deposition in foam cells, and inhibit the secretion of TNF-α and IL-1β by foam cells. Conclusion It is proved that the effective components of Xiongshao capsule, ligustrazine and paeoniflorin, can reduce the cholesterol content in foam cells derived from RAW264.7 cells and reduce the inflammatory factors, TNF-α and IL-1β produced by foam cells which have an potential ability to inhibit inflammatory reaction.

    Reference
    [1] Cichon N, Lach D, Dziedzic A, et al.The inflammatory processes in atherogenesis.Pol Merkur Lekarski, 7,2(249):125-128.
    [2] Galea J, Armstrong J, Gadsdon P, et al.Interleukin-1 beta in coronary arteries of patients with ischemic heart disease .Arterioscler Thromb Vasc Biol, 6,6(8):1000-1006.
    [3] Skoog T, Dichtl W, Boquist S, et al.Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men .Eur Heart J, 2,3(5):376-383.
    [4] Khovidhunkit W, Moser AH, Shigenaga JK, et al.Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages:differential role of LXR .J Lipid Res, 3,4(9):1728-1736.
    [5] Ridker PM.From C-reactive protein to interleukin-6 to interleukin-1:moving upstream to identify novel targets for atheroprotection .Circ Res, 6,8(1):145-156.
    [6] Kirii H, Niwa T, Yamada Y, et al.Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice .Arterioscler Thromb Vasc Biol, 3,3(4):656-660.
    [7] Andrés V, Pello OM, Silvestre-Roig C.Macrophage proliferation and apoptosis in atherosclerosis .Curr Opin Lipidol, 2,3(5):429-438.
    [8] Ramji DP, Davies TS.Cytokines in atherosclerosis:key players in all stages of disease and promising therapeutic targets .Cytokine Growth Factor Rev, 5,6(6):673-685.
    [9] Ohta H, Wada H, Niwa T, et al.Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice .Atherosclerosis, 5,0(1):11-17.
    [10] 张艳虹, 徐凤芹.芎芍胶囊对动脉粥样硬化兔主动脉NF-κB及相关炎症因子的影响 .中华中医药杂志, 4,9(7):2334-2337.
    [11] Zhang YH, Zhang Y, Li J, et al.Protective effects of Xiongshao capsule on anti-inflammatory function of high-density lipoprotein in an atherosclerosis rabbit model .Chin J Integr Med, 7,3(5):357-361.
    [12] 张大武, 张蕾, 刘剑刚, 等.芎芍胶囊联合缺血后适应对大鼠缺血/再灌注心肌MCP-1及TNF-α的影响 .中国中西医结合杂志, 0,0(12):1279-1283.
    [13] 刘倩.白细胞介素-8对动脉粥样硬化斑块稳定性的影响及芎芍胶囊的干预效应研究.北京:中国中医科学院, 2012:53-60.
    [14] 祝骥, 滕耀红, 王萍儿, 等.川芎嗪对泡沫细胞胆固醇逆转运的影响.中国中药杂志, 4,9(7):1255-1259.
    [15] 唐菀泽, 马卫列, 丁航, 等.氧化芍药苷对泡沫细胞胆固醇流出的影响.中国现代医学杂志, 7,7(16):6-11.
    [16] 雷志丹, 雷志钧, 戴玲.HPLC同时测定川芎中川芎嗪和阿魏酸的含量.中国医药导报, 1,8(9):57-59.
    [17] 肖为蓉, 曹贤燮.裂解色谱法对川芎中川芎嗪的分析.华西药学杂志, 7,2(3):158-160.
    [18] 尹丹丹, 杨沫, 王运来, 等.基于川芎内生枯草杆菌初步研究川芎中川芎嗪的来源.中国中药杂志, 8,3(19):3893-3898.
    [19] 朱承科, 胡夏逢, 周诚.Box-Behnken效应面法优化川芎中川芎嗪的提取工艺.中药材, 6,9(9):2078-2080.
    [20] 朱美晓, 黄志芳, 肖红斌, 等.HPLC法测定川产道地药材川芎中川芎嗪的含量.药物分析杂志, 1,1(1):103-106.
    [21] Khera AV, Cuchel M, de la Llera-Moya M, et al.Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis .N Engl J Med, 1,4(2):127-135.
    [22] Chistiakov DA, Melnichenko AA, Myasoedova VA, et al.Mechanisms of foam cell formation in atherosclerosis .J Mol Med (Berl), 7,5(11):1153-1165.
    [23] Persson J, Nilsson J, Lindholm MW.Interleukin-1beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells .BMC Immunol, 8,1(9):E70.
    [24] Wang L, Zhou GB, Liu P, et al.Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia .Proc Natl Acad Sci USA, 8,5(12):4826-4831.
    [25] 周庆兵, 吴立旗, 徐凤芹.栀子苷对ox-LDL诱导的RAW264.7来源泡沫细胞DNA异常甲基化的双向调节作用 [J/OL].中国中西医结合杂志, 2019:1-6[2019-04-11].http://kns.cnki.net/kcms/detail/11.2787.R.20190213.1003.002.html.
    [26] Ozasa H, Ayaori M, Iizuka M, et al.Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARgamma/LXRalpha pathway:findings from in vitro and ex vivo studies .Atherosclerosis, 1,9(1):141-150.
    [27] Chawla A, Boisvert WA, Lee CH, et al.A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis .Mol Cell, 1,7(1):161-171.
    [28] Tang J, Luo K, Li Y, et al.Capsaicin attenuates LPS-induced inflammatory cytokine production by upregulation of LXRalpha .Int Immunopharmacol, 5,8(1):264-269.
    [29] Kim MS, Sweeney TR, Shigenaga JK, et al.Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells .Metabolism, 7,6(2):267-279.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

MEI Jun, ZHOU Qingbing, XU Hao, XU Fengqin. Synergistic effect of components of Xiongshao capsule on reducing cholesterol content and inflammation in foam cells derived from RAW264.7 cells[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2019,27(8):655-660.

Copy
Share
Article Metrics
  • Abstract:1013
  • PDF: 826
  • HTML: 0
  • Cited by: 0
History
  • Received:October 11,2018
  • Revised:February 19,2019
  • Online: July 08,2019
Article QR Code